ArticleThe Journal of dermatology2025
Comparative Effectiveness and Safety of Adalimumab, Secukinumab, and Upadacitinib in Psoriatic Arthritis: A Prospective Cohort Study Based on PARWCH Cohort.
Yiyi Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.